Forty eight patients having psoriasis were studied with puvasol therapy. Pre-treatment haemogram, platelet count, liver and renal functions were done. To begin with 40 mgm of 8 MOP were given at 10.30 a m and at 12.30 p m sunlight exposure for period varying from 5-30 minutes. After 8 to 12 weeks tri, bi and weekly maintenance therapy was given. The sunlight exposure calculated by the photometer was 8-12 Joules/cm2 per day. The grading of response was undertaken on the basis of three different aspects (1) Subsidence of lesions, Grades were given as excellent with 100% subsidence, good with 90100%, fair with 50-90% and poor with less than 50% subsidence (2) Statistical point score as per Wallace's classification and depending on type and morophology of lesions and (3) Response related to duration of therapy. Of 38 patients with psoriasis vulgaris 21 showed excellent to. good response. All six cases of psoriasis e ma (100%) showed excellent to good response. Of the three cases of pustular psoriasis, one showed 90- 100%, and 2, 50-90% subsidence. Puvasol therapy proved to be effective, non toxic and inexpensive in psoriasis. In the erythrodemic and pustular phase for the first time the results were encouraging.
Download full-text PDF |
Source |
---|
Skinmed
September 2024
Department of Dermatology, Mahatma Gandhi Medical College & Maharaja Yashwant Rao Hospital, Indore, Madhya Pradesh, India.
J Ethnopharmacol
October 2022
Drug Standardization Unit, National Research Institute of Unani Medicine, for Skin Disorders (NRIUMSD), Hyderabad, 500038, India. Electronic address:
Ethnopharmacological Relevance: Psoriasis, despite modern therapeutic options, is incurable and recurrent. In Unani (Greco-Arab) medicine, many medications and formulations have been prescribed by eminent scholars for conditions clinically similar to psoriasis, though empirical evidence is sparse. Hence, the experimental formulations ItrīfalShāhtra and MarhamḤina were chosen to be compared to the standard therapies PUVAsol and petrolatum for their safety and efficacy.
View Article and Find Full Text PDFJ Cosmet Dermatol
June 2022
Department of Dermatology, Afzalipour Faculty of Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran.
Background: Segmental vitiligo (SV) is a distinctive variant of vitiligo that is usually resistant to traditional treatments. Therefore, surgical therapies are mainstay of treatment in this type of vitiligo. To date, there is no review article or systematic review that evaluates specifically efficacy of treatment modalities on SV.
View Article and Find Full Text PDFIndian J Dermatol
January 2021
Department of Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal, India.
Background: COVID-19 pandemic has changed the approach of dermatologists, with respect to management of numerous conditions, vitiligo being one of them. However, there is a lack of consensus on how to deal with patients of vitiligo, as we battle this pandemic.
Aim: To conduct a questionnaire-based survey, amongst expert dermatologists; in order to understand the impact of COVID-19 on the management of vitiligo.
J Complement Integr Med
March 2023
Department of Moalajat, Luqman Unani Medical College Hospital & Research Center, Bijapur, Karnataka, India.
Objectives: Greco-Arab medicine is an ancient system of medicine with greater treasure on therapeutics of vitiligo. The trial Unani formulations have not been scientifically explored for their safety and efficacy, but have been repeatedly prescribed by the great Unani physicians in the management of (vitiligo). Hence, these interventions were selected for the trial.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!